Home » Prices » NASDAQ:CYCC

Cyclacel Pharmaceuticals, Inc. stock price

Today's NASDAQ:CYCC chart, history & news

Price:
3.85 USD
Change:
+0.12 (3.22%)
Key Stats
Price open 3.72
Previous close 3.73
Market cap 18.73M
Volume 97.58K
Day high 3.98
Day low 3.72
Year high 18.3
Year low 3.21
Year to date change -68.02%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Company information

Company name
Cyclacel Pharmaceuticals Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
12
CEO
Spiro Rombotis
Address
200 Connell Drive, Berkeley Heights, NJ, 07922
Country
United States
Contact information
1.908.517.7330
Website
http://www.cyclacel.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.